Lindbrook Capital, LLC Gossamer Bio, Inc. Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$7.21 - $14.88 $259 - $535	36 Added 15.19%	273 $3,000
Q2 2022 Aug 01, 2022	SELL	$5.97 - $9.97 $1,271 - $2,123	-213 Reduced 47.33%	237 $2,000
Q1 2022 Apr 21, 2022	BUY	$8.44 - $12.49 $3,798 - $5,620	450 New	450 $4,000
Q4 2021 Jan 18, 2022	SELL	$10.12 - $14.07 $15,179 - $21,105	-1,500 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$7.25 - $13.23 $10,875 - $19,845	1,500 New	1,500 $19,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $81.7M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.